Home › Stocks › NVCT › All Fund Holders
NVCT — NUVECTIS PHARMA INC · All Fund Holders
Funds holding (latest): 25 · Reported value held: $45.41M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.00M | $18.41M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 432.27K | $7.95M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 845.50K | $6.38M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 182.23K | $3.35M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 146.71K | $2.70M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 69.20K | $1.27M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 57.13K | $1.05M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 36.77K | $676.19K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 31.89K | $586.38K | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 20.48K | $376.63K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 18.72K | $344.28K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 16.87K | $310.31K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 15.59K | $286.77K | 0.00% | Add |
| Renaissance Technologies history | Q3 2025 | 42.80K | $257.66K | 0.00% | Hold |
| Millennium Management history | Q2 2025 | 31.17K | $232.82K | 0.00% | Reduce |
| Marshall Wace history | Q1 2026 | 29.22K | $225.89K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 11.87K | $218.29K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 7.09K | $202.31K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.06K | $148.24K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 8.02K | $147.40K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2025 | 13.48K | $131.73K | 0.00% | New |
| Two Sigma Investments history | Q3 2025 | 18.43K | $110.98K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 1.66K | $30.55K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 28 | $515 | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 13.80K | $254 | 0.00% | Add |